- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-Galectin-9
Galectin-9 Polyclonal Antibody for WB, IP, IF, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 17938-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules U-937, cellules HeLa, cellules HepG2, cellules HL-60, cellules NIH/3T3, cellules SGC-7901 |
Résultats positifs en IP | cellules U-937, |
Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 10 publications below |
IHC | See 4 publications below |
IP | See 1 publications below |
Informations sur le produit
17938-1-AP cible Galectin-9 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | Galectin-9 Protéine recombinante Ag12209 |
Nom complet | lectin, galactoside-binding, soluble, 9 |
Masse moléculaire calculée | 323 aa, 36 kDa |
Poids moléculaire observé | 45 kDa |
Numéro d’acquisition GenBank | BC110340 |
Symbole du gène | Galectin-9 |
Identification du gène (NCBI) | 3965 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The galectins, formerly known as S-type lectins, are a family of β-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-9 (LGALS9) is a tandem repeat-type member of the galectin family. It has three isoforms (named galectin-9L, galectin-9M, and galectin-9S): long type of 355 amino acids, medium type of 323 amino acids, and short type of 311 amino acids. Galectin-9 is ubiquitously expressed in a variety of tissues, including lymph nodes and spleen, and overexpressed in Hodgkin disease tissue. It is involved in chemoattraction, apoptosis, and the regulation of cell differentiation and has anti-allergic effects. It has been reported that galectin-9 is a ligand for Tim-3, through which galectin-9 can induce T-helper type 1 lymphocyte (Th1) death.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for Galectin-9 antibody 17938-1-AP | Download protocol |
IF protocol for Galectin-9 antibody 17938-1-AP | Download protocol |
IP protocol for Galectin-9 antibody 17938-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Front Mol Neurosci Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease | ||
J Nutr Biochem Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression | ||
Front Immunol Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion. | ||
Stem Cell Res Ther Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. | ||
Immunotherapy Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer |